Saudi FDA approves first AI-powered medical software for dentistry and ophthalmology
Saudi Food and Drug Authority grants marketing approval to locally developed Dental IQ and SAARIA AI programs for dental and eye diagnostics.
Key Takeaways
AIThe Saudi Food and Drug Authority has granted marketing approval for the first two Saudi-developed medical software programs powered by artificial intelligence in the fields of dentistry and ophthalmology, following regulatory evaluation and verification of their safety and effectiveness for medical use.
The authority explained that the first program, Dental IQ, uses deep learning algorithms to analyze dental X-ray images, aiming for early detection of conditions such as tooth decay, gum disease, and changes related to dental and supporting tissue health. The software is designed to enhance diagnostic accuracy and support the development of appropriate treatment plans.
The second program, SAARIA, utilizes artificial intelligence to analyze retinal images, supporting the screening of diabetic patients and the early detection of diabetic retinopathy in healthcare facilities. The program helps accelerate referrals for cases requiring specialist evaluation and promotes early intervention to reduce disease complications.
Innovative Saudi medical software
The authority stated that these two programs represent the first Saudi medical software products approved with artificial intelligence in the fields of dentistry and ophthalmology, serving as decision-support tools for healthcare practitioners.
Both programs were developed by Saudi startup companies specializing in digital health solutions, after joining the authority's innovative medical devices track and completing all evaluation requirements. This included conducting clinical studies within the Kingdom and verifying performance in local use environments, in addition to committing to post-marketing clinical follow-up plans.
Supporting innovation in digital health
The authority emphasized that results from medical devices and software do not replace consultation with a specialist physician for accurate health assessment. The marketing approval for these programs is part of the authority's efforts to support innovation in the digital health sector and to enable the development and localization of advanced medical technologies, in line with the Health Sector Transformation Program goals under Saudi Vision 2030.